blindness with glp 1 NAION and GLP1s: Rare Cause of Linked to Medication | Michael Weintraub, MD posted on the topic David Sinclair: GLP-1 Blindness Risk

When to Consult Your Healthcare Provider Patients taking Wegovy should consult their GP or prescribing clinician before starting regular naproxen use, particularly if they plan to use it for more than a few days or require it frequently

Some patients find it helpful to use a mirror or ask a family member, carer, or healthcare professional to assist with arm injections, particularly when first learning the technique

#imstephiej #superpatch @Super Patch Company Please be careful Just a heads up for anyone seeing those miracle weight loss patches ads If it claims: lose weight fast no diet or exercise needed fixes EVERYTHING (fat, skin, energy, blood sugar, etc.) its probably NOT legit

Pancreatitis risk appears slightly elevated with all incretin-based therapies

Unmasked mental health patterns need attention not more time

Exenatide retains historical significance as the first GLP-1 agonist and may serve as a lower-cost option in resource-limited settings, but liraglutide is the preferred agent for new prescriptions among these two options